Opiant Pharmaceuticals to Participate in September Investor Conferences
August 25 2021 - 4:05PM
Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT) today
announced that members of the company’s senior management team will
participate in the following virtual investor conferences:
- H.C. Wainwright 23rd Annual Global Investment
ConferenceSeptember 13-15, 2021On-demand presentation will
be available at 7:00am ET on September 13; hosting 1-on-1
meetings
- Oppenheimer Fall Healthcare Life Sciences &
MedTech SummitSeptember 20-23, 2021Presentation
on September 20 at 4:35 pm ET; hosting 1-on-1
meetings
- Cantor 2021 Virtual Global Healthcare
Conference September 27-30, 2021Fireside chat
on September 29 at 4:00 pm ET; hosting 1-on-1
meetings
A webcast of each presentation and fireside chat will be
accessible on the Opiant website.
About Opiant Pharmaceuticals,
Inc. Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose. For more information
visit: www.opiant.com.
For Media and Investor Inquiries:Ben Atkins, Opiant(310)
598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Apr 2023 to Apr 2024